Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.
Stephen H RappaportJenna M ClarkSamantha DelibertKaylee M MaynardParitosh PrasadDavid C KaufmanAnthony P PietropaoliCaroline M QuillChristine M GrothPublished in: American journal of respiratory and critical care medicine (2020)